James Mackin

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX.

Genzyme Biosurgery develops and manufactures bio-therapeutic and bio-material products. Its products include Osteoarthritis Relief, Adhesion Prevention, Cartilage Repair, Severe Burn Treatment, and Bulk HA Platform. The company is headquartered in Cambridge, MA.

Opsens, Inc. engages in the development, manufacture, supply, and installation of fiber optic systems for measuring pressure and temperature. It operates through the Medical and Industrial business segments. The Medical segment focuses on the physiological measurement in interventional cardiology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for critical applications such as the monitoring of oil wells and demanding industrial applications. The company was founded in 2003 and is headquartered in Quebec, Canada.

Part of Japan Lifeline Co., Ltd., Cardiac Rhythm Management is a company that manufactures implantable devices to treat arrhythmias. The company is based in Sylmar, CA.

Part of Artivion, Inc., CryoLife Europa Ltd. is a British company that sells and distributes medical devices. The company is based in Guildford, UK.

Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.